The enlarged group was re-admitted to AIM and Euronext Growth on 20th January 2020 and completed a placing of £5.3 million on 31 January 2020.
Open Orphan Plc are building a leading European specialist pharmaceutical services company which includes a focus on orphan drug services by acquiring and consolidating a series of European services companies.
hVIVO Plc is an industry leading services provider in the viral challenge studies and virology laboratory services. It has developed a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases.
It is hoped the merger will result in synergies across the Enlarged Group with each business providing complementary services with limited overlap in existing capabilities and customers.
Jeffreys Henry LLP acted as the Reporting Accountant in respect of the merger and subsequent re-admission.
This latest announcement further strengthens Jeffreys Henry LLP’s credentials within the AIM market.
Earlier this year, Jeffreys Henry LLP rose to 10th place in the latest league table of Auditors ranked by Total of Stock Market clients.
With a total of 27* UK listed clients, a dedicated capital markets team and shorter reporting lines, Jeffreys Henry LLP is able to offer a cost-effective AIM audit service for companies already listed, or considering listing, on the London Stock Exchange, AIM, NEX and other European markets.
*As of January 2020
Partner - Capital Markets
Partner - Capital Markets
Jeffreys Henry, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has advised Aptamer Group Plc on its £80.7 million AIM IPO. On Admission, the market capitalisation of Aptamer Group was approximately £80.7 million. The Placing raised gross proceeds of £10.8 million and attracted strong support from high-quality institutional investors.
Jeffreys Henry, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has recently advised Technology Minerals Plc on its £27.3 million IPO on the Standard Segment of LSE’s Main Market.
Poolbeg Pharma, a spin out of Open Orphan, has successfully raised £25 million (before expenses) and lists with a market capitalisation of £50 million. Poolbeg Pharma is a clinical-stage infectious disease pharmaceutical company. Their novel capital light clinical model enables them to develop multiple products faster and more cost effectively than the traditional biotech model.
Jeffreys Henry LLP, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has advised Vector Capital Plc on its […]
Jeffreys Henry LLP, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has advised Intuitive Investments Group on its […]
Jeffreys Henry LLP, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has recently advised Anemoi International (“AMOI”) on its IPO on the Standard Segment of LSE’s main market.
Jeffreys Henry LLP, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has recently advised Mode Global Holdings Plc, a UK based founder led fintech group, on its £40.3 million IPO on the Standard Segment of LSE’s main market.
We are delighted to announce that our specialist Capital Markets team have been shortlisted for one of the most hotly-contested trophies in the accountancy profession: Specialist Team of the Year 2020.
We are pleased to announce that Jeffreys Henry LLP has replaced KPMG as auditor to AIM listed Premier African Minerals (AIM:PREM). Premier African Minerals Limited was […]
We are pleased to announce that Jeffreys Henry LLP has replaced RSM as auditor to AIM listed Alien Metals (LSE: UFO). Alien Metals Ltd is a mining exploration and development company listed on AIM of the London Stock Exchange with a focus on precious and base metal commodities.